No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NVRO Nevro
- 11.520
- +0.200+1.77%
Trading Apr 29 12:01 ET
422.57MMarket Cap-4500P/E (TTM)
11.699High11.370Low63.27KVolume11.650Open11.320Pre Close730.33KTurnover0.18%Turnover RatioLossP/E (Static)36.68MShares28.89052wk High1.44P/B409.07MFloat Cap11.26052wk Low--Dividend TTM35.51MShs Float188.140Historical High--Div YieldTTM2.90%Amplitude11.260Historical Low11.543Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Nevro Corp Announces Chief Accounting Officer Resignation
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today...
RBC Capital Sticks to Their Hold Rating for Nevro Corp (NVRO)
Nevro Is Maintained at Sector Perform by RBC Capital
Nevro Is Maintained at Sector Perform by RBC Capital
RBC Capital Maintains Sector Perform on Nevro, Lowers Price Target to $16
RBC Capital analyst Shagun Singh maintains Nevro (NYSE:NVRO) with a Sector Perform and lowers the price target from $18 to $16.
Express News | Nevro Corp : RBC Cuts Target Price to $16 From $18
Comments
Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.
Benign Growth For Nevro Corp. (NYSE:NVRO) Underpins Its Share Price 1
Nevro's growth strategy, prioritizing expansion over steady profits, is viewed as risky, leading to a rapidly declining share price. Despite insider purchases, the company's overall performance has been disappointing, resulting in an annual loss of 8% for shareholders over five years.
Insiders buying shares over the past year, including one at a price higher than current, signals positive views of the company's future. While no insider transactions happened in recent three months, activities over the year suggest firm belief in potential.
The disappointing performance of Nevro's stock may be due to low growth and profit rates. Despite insider purchases, market sentiment towards Nevro remains negative, possibly an overreaction.
Despite Nevro's stock price plummeting, insiders buying shares in the past year, the company's ascent looks doubtful without significant profits and revenue growth.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg